Ikuo Takazawa

ORCID: 0000-0003-1640-5806
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • NF-κB Signaling Pathways
  • Systemic Lupus Erythematosus Research
  • Signaling Pathways in Disease
  • Abdominal vascular conditions and treatments
  • Macrophage Migration Inhibitory Factor
  • Digestive system and related health
  • Congenital gastrointestinal and neural anomalies
  • Helicobacter pylori-related gastroenterology studies
  • Endoplasmic Reticulum Stress and Disease

The University of Tokyo
2023-2024

Crohn's disease is a chronic, debilitating, inflammatory bowel disease. Here, we report critical role of phospholipase C-β3 (PLC-β3) in intestinal homeostasis. In PLC-β3-deficient mice, exposure to oral dextran sodium sulfate induced lethality and severe inflammation the small intestine. The was due PLC-β3 deficiency multiple non-hematopoietic cell types. resulted reduced Wnt/β-catenin signaling, which essential for homeostasis regeneration epithelium. regulated pathway epithelial cells...

10.3390/cells13110986 article EN cc-by Cells 2024-06-05

is a negative regulator of T cell activation and one the key activators type I interferon (IFN) NFκB signaling via non-classical pathways. The upstream single nucleotide polymorphism

10.3389/fimmu.2024.1475179 article EN cc-by Frontiers in Immunology 2024-10-25

Click to increase image sizeClick decrease size Disclosure statementTK has received speaking fees and/or honoraria from Tanabe Mitsubishi, Kissei, Pfizer, Amgen, Chugai, Daiichi-Sankyo, Eli Lilly, Eisai, Novartis, and Janssen, grants GlaxoSmithKline. HS Bristol-Myers Squibb, Sanofi, AbbVie, GlaxoSmithKline, Gilead, Boehringer Ingelheim, Jansen, Astellas, Asahi Kasei, Taisho Pharmaceutical, AstraZeneca, Daiichi-Sankyo. KF Ono, Ayumi, Daiichi Sankyo, research Tsumura, Kasei. The other authors...

10.1080/03009742.2023.2178772 article EN Scandinavian Journal of Rheumatology 2023-02-23
Coming Soon ...